FDA Inspection
Jiangxi Fushine Pharmaceutical Co., Ltd.Jiangxi Fushine Pharmaceutical Co., Ltd. – FDA Inspection, Aug 14, 2025
Record Details
This FDA Inspection record concerns Jiangxi Fushine Pharmaceutical Co., Ltd., with an inspection on August 14, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- August 14, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 4646763e-feb9-4289-928d-ce7df0e4a3ed
Inspection Facts
- Inspection number
- 1280551
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Jiangxi Fushine Pharmaceutical Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 18, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 4, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Jiangxi Fushine Pharmaceutical Co., Ltd.
- FDA Inspection 1084105 - 2019-01-18
- FDA Inspection 892989 - 2014-07-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.